Drugs / Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02040636 | Jan 1999 → May 2000 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02040636 ↗ |
| Modality | Vaccine | “Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV” NCT02040636 ↗ |